306 related articles for article (PubMed ID: 33058207)
21. ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
Yanai M; Kojima S; Sakai M; Komorizono R; Tomonaga K; Makino A
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852792
[TBL] [Abstract][Full Text] [Related]
22. The "new favorite" of gene editing technology-single base editors.
Wei Y; Zhang XH; Li DL
Yi Chuan; 2017 Dec; 39(12):1115-1121. PubMed ID: 29258982
[TBL] [Abstract][Full Text] [Related]
23. Programmable RNA base editing with a single gRNA-free enzyme.
Han W; Huang W; Wei T; Ye Y; Mao M; Wang Z
Nucleic Acids Res; 2022 Sep; 50(16):9580-9595. PubMed ID: 36029126
[TBL] [Abstract][Full Text] [Related]
24. SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates.
Shanmugam R; Zhang F; Srinivasan H; Charles Richard JL; Liu KI; Zhang X; Woo CWA; Chua ZHM; Buschdorf JP; Meaney MJ; Tan MH
Nucleic Acids Res; 2018 Aug; 46(14):7379-7395. PubMed ID: 29992293
[TBL] [Abstract][Full Text] [Related]
25. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
26. New Frontiers for Site-Directed RNA Editing: Harnessing Endogenous ADARs.
Merkle T; Stafforst T
Methods Mol Biol; 2021; 2181():331-349. PubMed ID: 32729089
[TBL] [Abstract][Full Text] [Related]
27. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
Dawson TR; Sansam CL; Emeson RB
J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
[TBL] [Abstract][Full Text] [Related]
28. Novel exon of mammalian ADAR2 extends open reading frame.
Maas S; Gommans WM
PLoS One; 2009; 4(1):e4225. PubMed ID: 19156214
[TBL] [Abstract][Full Text] [Related]
29. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides.
Merkle T; Merz S; Reautschnig P; Blaha A; Li Q; Vogel P; Wettengel J; Li JB; Stafforst T
Nat Biotechnol; 2019 Feb; 37(2):133-138. PubMed ID: 30692694
[TBL] [Abstract][Full Text] [Related]
30. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
31. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
32. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
[TBL] [Abstract][Full Text] [Related]
33. An efficient system for selectively altering genetic information within mRNAs.
Montiel-González MF; Vallecillo-Viejo IC; Rosenthal JJ
Nucleic Acids Res; 2016 Dec; 44(21):e157. PubMed ID: 27557710
[TBL] [Abstract][Full Text] [Related]
34. Base editors for simultaneous introduction of C-to-T and A-to-G mutations.
Sakata RC; Ishiguro S; Mori H; Tanaka M; Tatsuno K; Ueda H; Yamamoto S; Seki M; Masuyama N; Nishida K; Nishimasu H; Arakawa K; Kondo A; Nureki O; Tomita M; Aburatani H; Yachie N
Nat Biotechnol; 2020 Jul; 38(7):865-869. PubMed ID: 32483365
[TBL] [Abstract][Full Text] [Related]
35. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
37. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
38. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
[TBL] [Abstract][Full Text] [Related]
39. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
40. Altered RNA editing in mice lacking ADAR2 autoregulation.
Feng Y; Sansam CL; Singh M; Emeson RB
Mol Cell Biol; 2006 Jan; 26(2):480-8. PubMed ID: 16382140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
